Tag: inspection

Case Study: Executing a Batch with Expired SOP During Scale-Up and Its Impact on Compliance In the high-stakes environment of pharmaceutical manufacturing, adherence to Standard Operating Procedures (SOPs) is non-negotiable.…

Analyzing Deviation Recurrence in Batches During Changeover: Lessons from CAPA Failures In an increasingly regulated pharmaceutical environment, the occurrence of deviations during batch changeovers can significantly disrupt manufacturing operations. Such…

Case Study: Investigating Deviation Recurrence in a Commercial Campaign In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practice (GMP) is crucial for maintaining product quality and safety. However, deviations can…

Breakdown of FDA Inspection Observations Related to Unapproved Process Parameter Changes During Tech Transfer In the pharmaceutical manufacturing environment, process integrity is essential to ensure compliance with Good Manufacturing Practices…

Case Study: Addressing Unapproved Process Changes During Scale-Up and Evaluating CAPA Effectiveness In the pharmaceutical manufacturing industry, maintaining compliance with regulatory standards is critical. A significant risk arises when process…

Assessing the Regulatory Implications of Unapproved Process Changes During Inspection Preparation In a highly regulated industry like pharmaceuticals, deviations from established processes can lead to significant compliance issues, especially during…

Analyzing Deviation Recurrence Across Batches During Technology Transfer: A Comprehensive Case Study In the robust environment of pharmaceutical manufacturing, maintaining compliance and ensuring product integrity is paramount. A notable challenge…

Investigation of Critical IPC Missing During Scale-Up and FDA Inspection Outcomes The successful scale-up of pharmaceutical products can be riddled with challenges, particularly in manufacturing controls where critical In-Process Controls…

Addressing Unapproved Process Parameter Changes During a Commercial Campaign In the realm of pharmaceutical manufacturing, adherence to established process parameters is paramount to ensure product quality and compliance with regulatory…

CAPA Ineffectiveness Revealed in Unauthorized Process Change During Changeover In the highly regulated pharmaceutical manufacturing industry, adherence to approved processes and quality systems is paramount. This case study explores a…

Analyzing Unplanned Hold Time Extensions During Tech Transfers: A Comprehensive Case Study Unplanned hold time extensions during technical transfers can pose significant risks to pharmaceutical manufacturing, raising concerns about product…

Examining Unapproved Process Parameter Changes During Scale-Up: A Case Study In pharmaceutical manufacturing, strict adherence to established process parameters is crucial to ensure product quality and compliance with regulatory standards.…